We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Xoma's Gevokizumab Fails Phase III Trial

News   Jul 23, 2015

 
Xoma's Gevokizumab Fails Phase III Trial
 
 
 

RELATED ARTICLES

Having a Heavier First-Born or Shorter Pregnancy May Increase Mother’s Breast Cancer Risk

News

Short first pregnancies and having a heavier first-born child may slightly increase a mother’s risk of breast cancer, a new study has found.

READ MORE

What Pneumococcus Says to Make You Sick

News

This study of "bacterial linguistics," attempts to identify the "words" that bacteria use to communicate.

READ MORE

Previously Unknown Role for Basophils in the Lung

News

Basophils, immune cells mainly known in the context of allergy, found to play a crucial role in the development of macrophages in the lung.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE